mithramycin A
(CFCUWKMKBJTWLW-BKHRDMLASA-N)
Structure
- SMILES
- CO[C@@H]([C@@H]1Cc2cc3cc(O[C@@H]4O[C@H](C)[C@H]([C@@H](C4)O[C@H]4C[C@@H](O)[C@@H]([C@H](O4)C)O)O)c(c(c3c(c2C(=O)[C@H]1O[C@@H]1O[C@H](C)[C@H]([C@@H](C1)O[C@@H]1O[C@H](C)[C@@H]([C@@H](C1)O[C@@H]1O[C@H](C)[C@H]([C@@](C1)(C)O)O)O)O)O)O)C)C(=O)[C@H]([C@H](O)C)O
- Type(s)
- Approved; Investigational; Withdrawn
- ATC code(s)
- L01DC02
- Molecular Formula:
- C52H76O24
- Molecular Weight:
- 1085.150
- Log P:
- -0.2493
- Hydrogen Bond Acceptor:
- 24
- Hydrogen Bond Donor:
- 11
- TPSA:
- 358.2
- CAS Number(s):
- 18378-89-7; 97666-60-9
Synonym(s)
1.
mithramycin A
External Link(s)
| MeSH | C066851 |
| PubChem Compound | 163659 |
| ChEBI | 31856 |
| CHEMBL | CHEMBL257619 CHEMBL1237054 |
| DrugBank | DB06810 |
| DrugCentral | 2223 |
| IUPHAR/BPS Guide to PHARMACOLOGY | 8394 |
| KEGG | cpd:C12389 dr:D00468 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cardiomyopathies | 172214 | CTD | |
| 2 | Chemical and Drug Induced Liver Injury | 24907531 | CTD | |
| 3 | Hypercalcemia | 11261509 | CTD | |
| 4 | Neoplasm Invasiveness | 19799886 | CTD | |
| 5 | Neoplasms | 11261509 | CTD | |
| 6 | Rhabdomyosarcoma | 857581 | CTD | |
| 7 | Testicular Neoplasms | 24907531 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.